Valeant, AstraZeneca to Partner on Brodalumab; Valeant to Make Upfront Payment to AstraZeneca of $100M; Up to $345M in Milestone Payments
September 01, 2015 at 04:35 AM EDT
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) today announced that its affiliate has entered into a collaboration agreement ...
